Affiliation:
1. Faculty of Pharmacy, Dr. A.P.J. Abdul Kalam Technical University, Lucknow, India
2. Department of Pharmaceutical, Goel Institute
of Pharmaceutical Sciences, Lucknow, India
3. Department of Emergency Medicine, Dr Ram Manohar Lohia Institute of Medical
Sciences, Lucknow, 226010, India
4. Department of Science, Maharishi University of Information Technology, Lucknow, India
Abstract
Abstract:
In underdeveloped nations, colorectal carcinogenesis (CRC) is a significant health issue. It is the third most
common outcome of cancer death. Despite a variety of therapy options, new medications are needed to lessen the severity
of this condition. In the colon, adenomatous polyps are the most common cause of CRC, occurring in 45 percent
of cases, particularly in patients over 60 years old. Inflammatory polyps are acquiring popularity in CRC, as well as
inflammation appears to exert a function in the disease, according to mounting research. The azoxymethane, dimethyl
hydrazine, APCmin/+ mouse model, and a combination of sulfated polysaccharides composed of dextran and sulfated
and dimethylhydrazine are among the experimental models used to study CRC in animals. Numerous signal transduction
pathways are engaged as CRC progresses. The p53, TGF-β, Delta-Notch, Salvador-Warts-Hippo (SWH), and
Kelch-like ECH associated protein 1 pathways are among the key signal transduction pathways. To decide cell destiny,
several signalling pathways work in tandem with the death of cell modalities, such as autophagy, necroptosis,
and apoptosis. In our lab, we have spent a lot of time looking into the cell signalling and mechanisms of cell death in
CRC. The pathogenesis of CRC, as well as the associated cell death and cell signalling pathways, are summarised in
this study.
Publisher
Bentham Science Publishers Ltd.
Subject
Cancer Research,Pharmacology,Molecular Medicine